What is Embecta Corp's earnings per share (EPS)?

Embecta Corp (EMBC) reported diluted earnings per share of $1.62 for fiscal year 2025. This represents a 20.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Embecta Corp Financials

EMBC

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE September

This page shows Embecta Corp (EMBC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EMBC FY2025 2026-05-05

FY2025 shows a cash-generation recovery driven by expense cuts and lighter reinvestment, not by stronger sales or product margins.

After the prior year’s trough, operating cash flow rose to $191.7M from $35.7M even as revenue slipped, so the rebound came from a leaner cost base rather than demand improvement. That is reinforced by operating margin expanding to 22.4% as gross margin fell to 62.6%, which points to overhead and R&D restraint, not stronger underlying product economics.

Liquidity and solvency are telling different stories: the current ratio improved to 2.4x, yet liabilities still exceeded assets by $650.6M. That combination means near-term obligations look manageable, but the company is still operating with a debt-heavy capital structure that leaves less room for a prolonged earnings setback.

Cash generation is being used to shrink leverage more than to build cash, with long-term debt down to $1.39B while cash declined to $225.5M. Because capital spending was only $9.3M, the latest $182.4M of free cash flow looks more like an efficiency-and-deleveraging year than a reinvestment-heavy one, which helps explain why cash recovered faster than sales.

Financial Health Signals

Financial Health Score 55/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Embecta Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Embecta Corp has an operating margin of 22.4%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 79/100, reflecting efficient cost management and pricing power. This is up from 14.8% the prior year.

Growth

Embecta Corp's revenue declined 3.8% year-over-year, from $1.1B to $1.1B. This contraction results in a growth score of 26/100.

Leverage

Embecta Corp has elevated debt relative to equity (D/E of -2.13), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.41, Embecta Corp holds $2.41 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 67/100.

Cash Flow

Embecta Corp converts 16.9% of revenue into free cash flow ($182.4M). This strong cash generation earns a score of 66/100.

Altman Z-Score Distress

1.62

Embecta Corp scores 1.62, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Embecta Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.01x

For every $1 of reported earnings, Embecta Corp generates $2.01 in operating cash flow ($191.7M OCF vs $95.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY-3.8%

5Y CAGR-0.1%

Embecta Corp generated $1.1B in revenue in fiscal year 2025. This represents a decrease of 3.8% from the prior year.

EBITDA

$282.8M

YoY+39.3%

5Y CAGR-11.6%

Embecta Corp's EBITDA was $282.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 39.3% from the prior year.

Net Income

$95.4M

YoY+21.8%

5Y CAGR-25.9%

Embecta Corp reported $95.4M in net income in fiscal year 2025. This represents an increase of 21.8% from the prior year.

EPS (Diluted)

$1.62

YoY+20.9%

5Y CAGR-26.4%

Embecta Corp earned $1.62 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$182.4M

YoY+816.6%

5Y CAGR-16.8%

Embecta Corp generated $182.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 816.6% from the prior year.

Cash & Debt

$225.5M

YoY-15.7%

Embecta Corp held $225.5M in cash against $1.4B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.60

YoY+0.0%

Embecta Corp paid $0.60 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

58M

YoY+1.4%

Embecta Corp had 58M shares outstanding in fiscal year 2025. This represents an increase of 1.4% from the prior year.

Margins & Returns

Gross Margin

62.6%

YoY-2.8pp

5Y CAGR-7.6pp

Embecta Corp's gross margin was 62.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.8 percentage points from the prior year.

Operating Margin

22.4%

YoY+7.6pp

5Y CAGR-22.4pp

Embecta Corp's operating margin was 22.4% in fiscal year 2025, reflecting core business profitability. This is up 7.6 percentage points from the prior year.

Net Margin

8.8%

YoY+1.9pp

5Y CAGR-30.6pp

Embecta Corp's net profit margin was 8.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.9 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$37.3M

YoY-52.7%

5Y CAGR-9.5%

Embecta Corp invested $37.3M in research and development in fiscal year 2025. This represents a decrease of 52.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$9.3M

YoY-41.1%

5Y CAGR-26.0%

Embecta Corp invested $9.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 41.1% from the prior year.

EMBC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.1B-3.8%	$1.1B+0.2%	$1.1B-0.8%	$1.1B-3.1%	$1.2B+7.4%	$1.1B
Cost of Revenue	$403.6M+4.0%	$387.9M+4.6%	$370.9M+4.6%	$354.6M-2.8%	$364.9M+13.0%	$322.9M
Gross Profit	$676.8M-7.9%	$735.2M-2.0%	$749.9M-3.2%	$774.9M-3.2%	$800.4M+5.0%	$762.6M
R&D Expenses	$37.3M-52.7%	$78.8M-7.5%	$85.2M+27.4%	$66.9M+5.7%	$63.3M+3.1%	$61.4M
SG&A Expenses	$332.0M-9.1%	$365.1M+7.0%	$341.3M+15.8%	$294.8M+22.7%	$240.3M+11.9%	$214.7M
Operating Income	$242.1M+45.1%	$166.8M-24.7%	$221.5M-28.5%	$309.6M-37.1%	$492.0M+1.1%	$486.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$40.9M+219.9%	-$34.1M-196.6%	$35.3M+7.0%	$33.0M-58.8%	$80.1M+37.6%	$58.2M
Net Income	$95.4M+21.8%	$78.3M+11.2%	$70.4M-68.5%	$223.6M-46.1%	$414.8M-3.0%	$427.6M
EPS (Diluted)	$1.62+20.9%	$1.34+9.8%	$1.22-68.6%	$3.89-46.6%	$7.28-2.9%	$7.50

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$221.8M-15.1%	$261.2M-1.1%	$264.0M-10.7%	$295.5M+14.1%	$259.0M-1.1%	$261.9M-8.5%	$286.1M+5.0%	$272.5M
Cost of Revenue	$94.0M-5.5%	$99.5M-5.7%	$105.5M+7.2%	$98.4M+3.7%	$94.9M-9.4%	$104.8M-6.7%	$112.3M+36.3%	$82.4M
Gross Profit	$127.8M-21.0%	$161.7M+2.0%	$158.5M-19.6%	$197.1M+20.1%	$164.1M+4.5%	$157.1M-9.6%	$173.8M-8.6%	$190.1M
R&D Expenses	$5.4M+17.4%	$4.6M0.0%	$4.6M+4.5%	$4.4M-45.0%	$8.0M-60.6%	$20.3M+2.5%	$19.8M-2.9%	$20.4M
SG&A Expenses	$76.2M-1.8%	$77.6M-10.7%	$86.9M+3.0%	$84.4M+6.0%	$79.6M-1.8%	$81.1M-16.2%	$96.8M+13.0%	$85.7M
Operating Income	$35.0M-58.0%	$83.3M+47.4%	$56.5M-39.9%	$94.0M+49.4%	$62.9M+119.2%	$28.7M+9.5%	$26.2M-53.1%	$55.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$13.6M-8.1%	$14.8M+469.2%	$2.6M-90.3%	$26.7M+117.1%	$12.3M+1857.1%	-$700K+96.8%	-$21.6M-275.6%	$12.3M
Net Income	-$4.1M-109.3%	$44.1M+67.0%	$26.4M-42.0%	$45.5M+93.6%	$23.5M	$0-100.0%	$14.6M-0.7%	$14.7M
EPS (Diluted)	$-0.07-109.5%	$0.74	N/A	$0.78+95.0%	$0.40	$0.00	N/A	$0.25

EMBC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.1B-15.1%	$1.3B+5.8%	$1.2B+11.8%	$1.1B+37.9%	$788.0M	N/A
Current Assets	$631.4M-17.0%	$761.0M+1.6%	$749.1M+12.7%	$664.7M+127.8%	$291.8M	N/A
Cash & Equivalents	$225.5M-15.7%	$267.5M-18.0%	$326.3M-1.4%	$330.9M	$0	$0
Inventory	$178.6M+4.1%	$171.5M+12.8%	$152.1M+23.9%	$122.8M+4.1%	$118.0M	N/A
Accounts Receivable	$145.6M-24.6%	$193.0M+1055.7%	$16.7M-24.8%	$22.2M-85.3%	$150.6M	N/A
Goodwill	$15.4M-1.3%	$15.6M0.0%	$15.6M-0.6%	$15.7M+0.6%	$15.6M	N/A
Total Liabilities	$1.7B-13.9%	$2.0B-0.6%	$2.0B+2.9%	$2.0B+921.1%	$193.7M	N/A
Current Liabilities	$261.5M-30.1%	$374.0M+5.8%	$353.5M+17.4%	$301.0M+83.5%	$164.0M	N/A
Long-Term Debt	$1.4B-11.3%	$1.6B-1.8%	$1.6B-0.3%	$1.6B	$0	N/A
Total Equity	-$650.6M+11.9%	-$738.3M+10.1%	-$821.7M+7.8%	-$891.4M-250.0%	$594.3M+3.9%	$572.2M
Retained Earnings	-$445.6M+10.6%	-$498.6M+7.9%	-$541.1M+6.2%	-$577.1M	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.0B-3.2%	$1.1B-2.5%	$1.1B-5.7%	$1.2B+3.3%	$1.1B-2.5%	$1.1B-10.6%	$1.3B+1.4%	$1.3B
Current Assets	$608.1M-2.0%	$620.2M-1.8%	$631.4M-7.4%	$681.5M+5.9%	$643.4M-3.6%	$667.2M-12.3%	$761.0M-2.6%	$781.1M
Cash & Equivalents	$184.9M-8.1%	$201.3M-10.7%	$225.5M-2.2%	$230.6M+10.2%	$209.3M-0.3%	$210.0M-21.5%	$267.5M-2.8%	$275.1M
Inventory	$192.6M+5.9%	$181.8M+1.8%	$178.6M-6.0%	$189.9M+12.2%	$169.2M+0.1%	$169.1M-1.4%	$171.5M-7.6%	$185.6M
Accounts Receivable	$147.1M-7.6%	$159.2M+9.3%	$145.6M-20.4%	$182.8M-1.5%	$185.6M+2.6%	$180.9M-6.3%	$193.0M+12.3%	$171.8M
Goodwill	$15.4M0.0%	$15.4M0.0%	$15.4M0.0%	$15.4M-0.6%	$15.5M0.0%	$15.5M-0.6%	$15.6M+0.6%	$15.5M
Total Liabilities	$1.7B-1.3%	$1.7B-3.7%	$1.7B-4.7%	$1.8B-1.6%	$1.9B-3.2%	$1.9B-5.2%	$2.0B-0.4%	$2.0B
Current Liabilities	$247.3M+5.4%	$234.7M-10.2%	$261.5M-5.1%	$275.5M+6.2%	$259.3M-13.0%	$298.2M-20.3%	$374.0M+0.9%	$370.7M
Long-Term Debt	$1.3B-2.7%	$1.4B-2.6%	$1.4B-4.8%	$1.5B-3.3%	$1.5B-1.7%	$1.5B-2.0%	$1.6B-1.6%	$1.6B
Total Equity	-$626.1M-2.1%	-$613.1M+5.8%	-$650.6M+2.8%	-$669.6M+9.0%	-$736.2M+4.2%	-$768.8M-4.1%	-$738.3M+3.3%	-$763.7M
Retained Earnings	-$424.7M-3.3%	-$411.1M+7.7%	-$445.6M+2.5%	-$457.1M+7.4%	-$493.5M+2.8%	-$507.9M-1.9%	-$498.6M+1.1%	-$504.2M

EMBC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$191.7M+437.0%	$35.7M-47.3%	$67.7M-83.6%	$412.2M-9.7%	$456.3M-8.5%	$498.5M
Capital Expenditures	$9.3M-41.1%	$15.8M-40.4%	$26.5M+12.3%	$23.6M-35.9%	$36.8M-12.2%	$41.9M
Free Cash Flow	$182.4M+816.6%	$19.9M-51.7%	$41.2M-89.4%	$388.6M-7.4%	$419.5M-8.1%	$456.6M
Investing Cash Flow	-$9.3M+41.1%	-$15.8M+40.4%	-$26.5M-10.4%	-$24.0M+38.8%	-$39.2M+6.4%	-$41.9M
Financing Cash Flow	-$226.7M-208.9%	-$73.4M-50.7%	-$48.7M-1.5%	-$48.0M+88.5%	-$417.1M+8.7%	-$456.6M
Dividends Paid	$35.0M+1.4%	$34.5M+0.3%	$34.4M+300.0%	$8.6M	$0	$0
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$31.1M+80.8%	$17.2M-79.5%	$84.0M+3.4%	$81.2M+155.3%	$31.8M+700.0%	-$5.3M-119.9%	$26.6M+1366.7%	-$2.1M
Capital Expenditures	$500K-16.7%	$600K-91.8%	$7.3M+1725.0%	$400K+300.0%	$100K-93.3%	$1.5M	$0-100.0%	$9.7M
Free Cash Flow	$30.6M+84.3%	$16.6M-78.4%	$76.7M-5.1%	$80.8M+154.9%	$31.7M+566.2%	-$6.8M-125.6%	$26.6M+325.4%	-$11.8M
Investing Cash Flow	-$500K-105.3%	$9.5M+230.1%	-$7.3M-1725.0%	-$400K-300.0%	-$100K+93.3%	-$1.5M	$0+100.0%	-$9.7M
Financing Cash Flow	-$41.5M+19.6%	-$51.6M+36.8%	-$81.6M-30.4%	-$62.6M-67.8%	-$37.3M+17.5%	-$45.2M-23.5%	-$36.6M-218.3%	-$11.5M
Dividends Paid	$8.9M0.0%	$8.9M+1.1%	$8.8M+1.1%	$8.7M0.0%	$8.7M-1.1%	$8.8M+1.1%	$8.7M+1.2%	$8.6M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

EMBC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	62.6%-2.8pp	65.5%-1.5pp	66.9%-1.7pp	68.6%-0.1pp	68.7%-1.6pp	70.3%
Operating Margin	22.4%+7.6pp	14.8%-4.9pp	19.8%-7.7pp	27.4%-14.8pp	42.2%-2.6pp	44.8%
Net Margin	8.8%+1.9pp	7.0%+0.7pp	6.3%-13.5pp	19.8%-15.8pp	35.6%-3.8pp	39.4%
Return on Equity	N/A	N/A	N/A	N/A	69.8%-4.9pp	74.7%
Return on Assets	8.8%+2.7pp	6.1%+0.3pp	5.8%-14.8pp	20.6%-32.1pp	52.6%	N/A
Current Ratio	2.41+0.4	2.03-0.1	2.12-0.1	2.21+0.4	1.78	N/A
Debt-to-Equity	-2.13-0.0	-2.12-0.2	-1.94-0.1	-1.79-1.8	0.00	N/A
FCF Margin	16.9%+15.1pp	1.8%-1.9pp	3.7%-30.7pp	34.4%-1.6pp	36.0%-6.1pp	42.1%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	57.6%-4.3pp	61.9%+1.9pp	60.0%-6.7pp	66.7%+3.3pp	63.4%+3.4pp	60.0%-0.8pp	60.8%-9.0pp	69.8%
Operating Margin	15.8%-16.1pp	31.9%+10.5pp	21.4%-10.4pp	31.8%+7.5pp	24.3%+13.3pp	11.0%+1.8pp	9.2%-11.3pp	20.5%
Net Margin	-1.8%-18.7pp	16.9%+6.9pp	10.0%-5.4pp	15.4%+6.3pp	9.1%+9.1pp	0.0%-5.1pp	5.1%-0.3pp	5.4%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-0.4%-4.5pp	4.2%+1.7pp	2.4%-1.5pp	3.9%+1.8pp	2.1%+2.1pp	0.0%-1.1pp	1.1%-0.0pp	1.2%
Current Ratio	2.46-0.2	2.64+0.2	2.41-0.1	2.470.0	2.48+0.2	2.24+0.2	2.03-0.1	2.11
Debt-to-Equity	-2.10+0.1	-2.21-0.1	-2.13+0.0	-2.18-0.1	-2.05-0.1	-2.00+0.1	-2.12-0.0	-2.08
FCF Margin	13.8%+7.4pp	6.4%-22.7pp	29.0%+1.7pp	27.3%+15.1pp	12.2%+14.8pp	-2.6%-11.9pp	9.3%+13.6pp	-4.3%

Note: Shareholder equity is negative (-$650.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

KESTRA MED TECHNOLOGIES LTD KMTS

$1.6B

Pulse Biosciences Inc PLSE

$1.9B

Biolife Solutions Inc BLFS

$1.4B

Staar Surg STAA

$1.4B

Angiodynamics ANGO

$533.8M

Frequently Asked Questions

What is Embecta Corp's annual revenue?

Embecta Corp (EMBC) reported $1.1B in total revenue for fiscal year 2025. This represents a -3.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Embecta Corp's revenue growing?

Embecta Corp (EMBC) revenue declined by 3.8% year-over-year, from $1.1B to $1.1B in fiscal year 2025.

Is Embecta Corp profitable?

Yes, Embecta Corp (EMBC) reported a net income of $95.4M in fiscal year 2025, with a net profit margin of 8.8%.

What is Embecta Corp's EBITDA?

Embecta Corp (EMBC) had EBITDA of $282.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Embecta Corp have?

As of fiscal year 2025, Embecta Corp (EMBC) had $225.5M in cash and equivalents against $1.4B in long-term debt.

What is Embecta Corp's gross margin?

Embecta Corp (EMBC) had a gross margin of 62.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Embecta Corp's operating margin?

Embecta Corp (EMBC) had an operating margin of 22.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Embecta Corp's net profit margin?

Embecta Corp (EMBC) had a net profit margin of 8.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Embecta Corp pay dividends?

Yes, Embecta Corp (EMBC) paid $0.60 per share in dividends during fiscal year 2025.

What is Embecta Corp's free cash flow?

Embecta Corp (EMBC) generated $182.4M in free cash flow during fiscal year 2025. This represents a 816.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Embecta Corp's operating cash flow?

Embecta Corp (EMBC) generated $191.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Embecta Corp's total assets?

Embecta Corp (EMBC) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Embecta Corp's capital expenditures?

Embecta Corp (EMBC) invested $9.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Embecta Corp spend on research and development?

Embecta Corp (EMBC) invested $37.3M in research and development during fiscal year 2025.

How many shares does Embecta Corp have outstanding?

Embecta Corp (EMBC) had 58M shares outstanding as of fiscal year 2025.

What is Embecta Corp's current ratio?

Embecta Corp (EMBC) had a current ratio of 2.41 as of fiscal year 2025, which is generally considered healthy.

What is Embecta Corp's debt-to-equity ratio?

Embecta Corp (EMBC) had a debt-to-equity ratio of -2.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Embecta Corp's return on assets (ROA)?

Embecta Corp (EMBC) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Embecta Corp's debt-to-equity ratio negative or unusual?

Embecta Corp (EMBC) has negative shareholder equity of -$650.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Embecta Corp's Altman Z-Score?

Embecta Corp (EMBC) has an Altman Z-Score of 1.62, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Embecta Corp's Piotroski F-Score?

Embecta Corp (EMBC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Embecta Corp's earnings high quality?

Embecta Corp (EMBC) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Embecta Corp?

Embecta Corp (EMBC) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.